Dr. Kutikov on Tumor Pathology in Renal Cell Carcinoma
Alexander Kutikov, MD, FACS, attending surgeon, urologic oncology, associate professor, urologic oncology, Fox Chase Cancer Center, discusses the understanding of tumor pathology in renal cell carcinoma.
Alexander Kutikov, MD, FACS, attending surgeon, urologic oncology, associate professor, urologic oncology, Fox Chase Cancer Center, discusses the understanding of tumor pathology in renal cell carcinoma.
Treatment of renal cell carcinoma has been boiled down to calibrating imbalanced risk, Kutikov explains. When consulting a patient who presents a renal mass, it is questionable whether to treat it or to use active surveillance. However, there needs to be a greater understanding of active surveillance and associated risks of that, he adds.
The urologic community is aiming to better understand tumor pathology in renal cell carcinoma, prior to tumor resection, Kutikov says. An example of this would be to better utilize renal biopsies.
<<<
